Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical ! Knowpia

Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers.

To order this 400+ page report, which features 240+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

The USD 15.7 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:

§ Phase of Development

§ Clinical

§ Preclinical

§ Types of Preclinical Services Offered

Biocompatibility testing

Sterility and microbiology testing

Material characterization and analytical services

Others

§ Types of Clinical Services Offered

Clinical trial management

Data management

Regulatory affairs management

Consulting

Others

§ Device Class

Class I medical devices

Class II medical devices

Class III medical devices

§ Target Therapeutic Area

§ CNS disorders

§ Cardiovascular disorders

§ Oncological disorders

§ Bone disorders

§ Respiratory disorders

§ Pain management disorders

§ Ophthalmic disorders

§ Psychological disorders

§ Metabolic disorders

§ Others

§ Key Geographical Regions

North America

Europe

Asia-Pacific

Rest of the World

The “Medical Device CRO Market (2^nd Edition), 2020-2030”. report features the following companies, which we identified to be key players in this domain:

§ Avania (formerly known as Factory CRO)

§ Charles River Laboratories

§ Clinlogix

§ CROMSOURCE

§ CSSi LifeSciences™

§ Eurofins Medical Device Testing

§ genae

§ IMARC Research

§ IQVIA

§ Medpace

§ NAMSA

§ Qserve Group